NuCana (NCNA) Net Cash Flow (2017 - 2025)

NuCana (NCNA) reported Net Cash Flow of -$1.3 million for Q4 2025, up 80.07% on a YoY basis from -$745323.1 in Q4 2024, and down 106.0% sequentially from $22.4 million in Q3 2025.

NuCana (NCNA) Net Cash Flow (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Net Cash Flow data on file, last reported at -$1.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 80.07% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at $21.0 million (up 251.98% YoY), and the FY2025 full-year result was $23.3 million, up 268.17% from the prior year.
  • Net Cash Flow fell to -$1.3 million in Q4 2025, from $22.4 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $22.4 million in Q3 2025 to a low of -$27.7 million in Q4 2021.
  • A 5-year average of -$6.2 million and a median of -$6.9 million in 2024 frame the typical range for Net Cash Flow.
  • Across the five-year window, Net Cash Flow sank 8000.1% in 2024 and jumped 18821.79% in 2025, its largest moves.
  • Tracing NCNA's Net Cash Flow over 5 years: stood at -$27.7 million in 2021, then surged by 41.39% to -$16.2 million in 2022, then surged by 99.49% to -$83157.2 in 2023, then slumped by 8000.1% to -$6.7 million in 2024, then jumped by 80.07% to -$1.3 million in 2025.
  • Business Quant data shows NCNA's Net Cash Flow at -$1.3 million in Q4 2025, $22.4 million in Q3 2025, and -$6.7 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 10.56 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 224.46 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.34 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 457.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -152.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 57.19 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 60.68 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.34 Mn
Dec 31, 2025 -1.34 Mn
Sep 30, 2025 22.37 Mn
Sep 30, 2025 22.37 Mn
Dec 31, 2024 -6.74 Mn
Dec 31, 2024 -6.74 Mn
Sep 30, 2024 118,236.32
Sep 30, 2024 118,236.32
Jun 30, 2024 -1.57 Mn
Jun 30, 2024 -1.57 Mn
Mar 31, 2024 -5.65 Mn
Mar 31, 2024 -5.65 Mn
Dec 31, 2023 -83,157.18
Dec 31, 2023 -83,157.18
Sep 30, 2023 -9.45 Mn
Sep 30, 2023 -9.45 Mn
Jun 30, 2023 -7.33 Mn
Jun 30, 2023 -7.33 Mn
Mar 31, 2023 -12.41 Mn
Mar 31, 2023 -12.41 Mn